Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Vivanza Biosciences LtdIndustry : Trading
BSE Code:530057NSE Symbol: Not ListedP/E(TTM):95.63
ISIN Demat:INE984E01035Div & Yield %:0EPS(TTM):0.08
Book Value(Rs):1.18Market Cap ( Cr.):30.6Face Value(Rs):1
    Change Company 
Date Headline
30-Apr-24 Vivanza Biosciences reports consolidated net loss of Rs0.41 crore in the March 2024 quarter
20-Apr-24 Vivanza Biosciences to hold board meeting
06-Feb-24 Vivanza Biosciences consolidated net profit declines 54.35% in the December 2023 quarter
06-Feb-24 Vivanza Biosciences Ltd - OUTCOME OF THE BOARD MEETING FOR UNAUDITED FINANCIAL RESULTS FOR QUARTER AND NINE MONTHS ENDED..
31-Jan-24 Vivanza Biosciences to convene board meeting
26-Oct-23 Vivanza Biosciences consolidated net profit rises 52.94% in the September 2023 quarter
26-Oct-23 Vivanza Biosciences standalone net profit rises 26.67% in the September 2023 quarter
26-Oct-23 Vivanza Biosciences Ltd - Board Meeting Outcome for Outcome Of Board Meeting For The Financial Results For The Quarter &..
26-Oct-23 Vivanza Biosciences Ltd - Results - Financial Results For September 30 2023 (Unaudited)
12-Oct-23 Vivanza Biosciences to announce Quarterly Result
<< < 1 2 > >>